Source link : https://newshealth.biz/health-news/inhaled-treprostinil-benefit-affirmed-in-idiopathic-pulmonary-fibrosis/
Nebulized treprostinil (Tyvaso) reduced lung function decline from idiopathic pulmonary fibrosis (IPF) in the pivotal TETON-1 trial, mirroring positive results from the parallel TETON-2 trial. Declines from baseline to week 52 for the primary endpoint of median change in forced vital capacity (FVC) came out significantly smaller with multiple daily doses of the prostacyclin vasodilator […]
The post Inhaled Treprostinil Benefit Affirmed in Idiopathic Pulmonary Fibrosis first appeared on News Health.
—-
Author : News Health
Publish date : 2026-05-19 14:52:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8